These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 21564347

  • 1. Evidence for a gut-brain axis used by glucagon-like peptide-1 to elicit hyperglycaemia in fish.
    Polakof S, Míguez JM, Soengas JL.
    J Neuroendocrinol; 2011 Jun; 23(6):508-18. PubMed ID: 21564347
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Glucagon-like peptides--synthesis, biological actions and some clinical implications].
    Otto Buczkowska E, Dworzecki T.
    Przegl Lek; 2004 Jun; 61(9):947-50. PubMed ID: 15803906
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of arginine on pancreatic hormones and hepatic metabolism in rainbow trout.
    Mommsen TP, Moon TW, Plisetskaya EM.
    Physiol Biochem Zool; 2001 Jun; 74(5):668-78. PubMed ID: 11517452
    [Abstract] [Full Text] [Related]

  • 8. Effect of different glycaemic conditions on gene expression of neuropeptides involved in control of food intake in rainbow trout; interaction with stress.
    Conde-Sieira M, Agulleiro MJ, Aguilar AJ, Míguez JM, Cerdá-Reverter JM, Soengas JL.
    J Exp Biol; 2010 Nov 15; 213(Pt 22):3858-65. PubMed ID: 21037065
    [Abstract] [Full Text] [Related]

  • 9. Glucagon-like peptide 1 and the brain: central actions-central sources?
    Trapp S, Hisadome K.
    Auton Neurosci; 2011 Apr 26; 161(1-2):14-9. PubMed ID: 20951098
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA, Walberg J, Vethacke A, El-Ouaghlidi A, Senkal M, Holst JJ, Gallwitz B, Schmidt WE, Schmiegel W.
    Regul Pept; 2004 Apr 15; 118(1-2):89-97. PubMed ID: 14759561
    [Abstract] [Full Text] [Related]

  • 12. Intracerebroventricular injection of glucagon-like peptide-1 changes lipid metabolism in chicks.
    Tachibana T, Oikawa D, Adachi N, Boswell T, Furuse M.
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Aug 15; 147(4):1104-8. PubMed ID: 17466552
    [Abstract] [Full Text] [Related]

  • 13. Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects.
    Steinert RE, Poller B, Castelli MC, Friedman K, Huber AR, Drewe J, Beglinger C.
    Clin Pharmacol Ther; 2009 Dec 15; 86(6):644-50. PubMed ID: 19727071
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM, Edgerton DS, Rodewald T, Scott M, Farmer B, Neal D, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2007 Oct 15; 293(4):E1085-91. PubMed ID: 17684104
    [Abstract] [Full Text] [Related]

  • 20. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes.
    Nauck MA, Holst JJ, Willms B, Schmiegel W.
    Exp Clin Endocrinol Diabetes; 1997 Oct 15; 105(4):187-95. PubMed ID: 9285204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.